Intravenous Calcium Gluconate Infusion Dosing for Acute Symptomatic Hypocalcemia
For continuous IV infusion after initial bolus, prepare 10 ampules of calcium gluconate (900 mg elemental calcium) in 1 liter of 5% dextrose or normal saline and infuse at 100 mL/h, adjusting based on serum calcium levels monitored every 6 hours. 1
Initial Bolus Dosing
The treatment algorithm begins with an IV bolus of 90-180 mg elemental calcium (1-2 grams calcium gluconate) administered over 10-20 minutes via a secure, large-bore IV with continuous cardiac monitoring 1. This translates to 10-20 mL of 10% calcium gluconate solution. Rapid infusion can cause cardiac arrest, making slow administration with ECG monitoring mandatory 1.
Indications for IV Calcium
IV calcium is warranted regardless of serum calcium level when:
- Severe symptoms present (seizures, laryngospasm, severe tetany)
- Prolonged QTc interval (>0.45s in men, >0.47s in women)
- Bronchospasm
- Patient unable to take oral supplements
- History of seizures 1
Even without these complications, IV therapy should be considered when albumin-corrected serum calcium falls below 7.5 mg/dL (1.9 mmol/L), though no universal threshold exists 1.
Continuous Infusion Protocol
After the initial bolus, transition immediately to continuous infusion:
- Preparation: Mix 10 ampules of calcium gluconate (providing 900 mg elemental calcium) into 1 liter of 5% dextrose or normal saline 1
- Starting rate: 100 mL/h 1
- Adjustment: Titrate based on serum calcium levels (albumin-corrected or preferably ionized calcium) 1
Critical Compatibility Warning
Never add bicarbonate or phosphate to the calcium infusion solution - they form insoluble calcium salts and precipitate 1, 2. This is a common pitfall that can render the infusion ineffective and potentially dangerous.
Monitoring Requirements
- During continuous infusion: Check serum calcium every 1-4 hours initially 2
- During intermittent infusions: Check every 4-6 hours 2
- After stabilization: Monitor every 6 hours, then daily until stable 1
- Goal: Restore calcium to just below the normal reference range 1
The FDA label emphasizes more frequent monitoring (every 1-4 hours) during continuous infusion compared to the guideline's recommendation of every 6 hours 2. In practice, start with hourly monitoring for the first 4-6 hours, then extend to every 4-6 hours once trending appropriately.
Expected Response
An IV dose of 15 mg/kg elemental calcium over 4-6 hours increases serum calcium by approximately 0.5-0.75 mmol/L 1. This provides a framework for dose adjustment, though individual responses vary significantly 3.
Concurrent Therapy
Simultaneously initiate:
- Oral calcitriol: 0.25-0.5 μg twice daily 1
- Alternative: Alfacalcidol 0.5 μg daily 1
- Correct hypomagnesemia if present - hypocalcemia will not resolve without adequate magnesium 1
Safety Considerations
Why Calcium Gluconate Over Calcium Chloride
Calcium gluconate is strongly preferred because it carries significantly lower risk of soft tissue necrosis if extravasation occurs 1. While calcium chloride provides more elemental calcium per volume (272 mg vs 90 mg per gram), this advantage is outweighed by safety concerns. If calcium chloride must be used, it should only be administered via central line 4.
Cardiac Monitoring
Continuous ECG monitoring is essential during bolus administration and advisable during infusion initiation 1, 2. Patients on cardiac glycosides require particularly close monitoring due to synergistic arrhythmia risk 2.
Extravasation Risk
Calcinosis cutis can occur with or without extravasation, potentially causing tissue necrosis, ulceration, and secondary infection 2, 5. If extravasation occurs or skin nodules develop, immediately discontinue the infusion at that site 2. Use a durable, secure IV with large-bore needle to minimize this risk 1.
Dose Adjustments for Special Populations
- Elderly patients: Start at the lower end of the dosage range 2
- Renal impairment: Initiate at lower limits and monitor serum calcium every 4 hours 2
- Pediatric dosing: 10-20 mg/kg elemental calcium for acute treatment 6
Common Pitfalls
- Infusing too rapidly - causes hypotension, bradycardia, and potentially cardiac arrest 2
- Mixing with incompatible solutions - bicarbonate and phosphate cause precipitation 1, 2
- Inadequate IV access - use large-bore, secure IV to prevent extravasation 1
- Forgetting magnesium - hypocalcemia won't correct without adequate magnesium 1
- Over-correction - target just below normal range, not high-normal, to minimize complications 1
The 2025 guideline evidence is remarkably consistent and provides clear, actionable protocols 1. The FDA labeling corroborates these recommendations while emphasizing more frequent monitoring 2.